Teva to Present at the Upcoming Investor Conferences in March
Teva Pharmaceutical Industries (TEVA) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]
Medincell: U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals [Yahoo! Finance]